Quantcast

Latest Adenocarcinoma Stories

2009-05-12 07:00:00

INDIANAPOLIS, May 12 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) will unveil data from more than 50 studies at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Fla. from May 29 to June 2, 2009, with the majority of the presentations continuing to support Lilly's leadership in thoracic cancer research. The company will present the latest research findings on ALIMTA(R) (pemetrexed for injection), as well as GEMZAR(R) (gemcitabine HCl for...

2009-05-04 13:04:06

Women are more likely to develop lung cancer from smoking than men, contracting the disease at younger ages, a Swiss study has determined. A study performed at the St. Gallen Canton Hospital found that female smokers tended to develop lung cancer at a younger age than men, even if they had smoked fewer cigarettes, the British tabloid The Daily Mail reported Monday. The newspaper said the hospital looked at 683 lung cancer patients treated between 2000 and 2005 and found that female smokers...

2009-03-13 13:34:00

New updates to the NCCN Guidelines for Pancreatic Adenocarcinoma were announced on March 12 at the NCCN 14th Annual Conference. Notable additions include updates on when a laparoscopy may be beneficial to patients, clarification on diagnostic imaging protocols, and an overall emphasis on systemic therapy in all disease stages. Pancreatic adenocarcinoma is the second most common cause of death from gastrointestinal cancer. HOLLYWOOD, Fla., March 13 /PRNewswire-USNewswire/ -- The National...

2009-03-10 14:25:00

Pathologists provide information on this potentially life-threatening disease during National Colorectal Cancer Awareness Month NORTHFIELD, Ill., March 10 /PRNewswire-USNewswire/ -- Colon cancer is the third most common cancer among men and women in the United States, excluding skin cancer. Affecting more than 140,000 Americans each year, pathologists say timing is critical when it comes to colon cancer -- early detection and treatment could save your life or the life of a loved one....

5b936332f5e10e3a63f968d368e344751
2008-11-17 14:02:51

Dutch researchers reported on Monday that smoking cigarettes and drinking alcohol may add to a person's risk of throat and stomach cancers. Jessie Steevens, an epidemiologist at Maastricht University in the Netherlands, and colleagues reported their findings at an American Association for Cancer Research meeting in Washington. Overall, researchers studied more than 120,000 Dutch participants for a period of more than two decades in order to determine their risks for Esophageal adenocarcinoma...

2008-11-05 21:00:13

U.S. researchers said they've decoded the genetic changes associated with a common form of lung cancer. The research team, led by scientists at Washington University School of Medicine in St. Louis, identified 26 genes that are frequently mutated in lung adenocarcinoma. The researchers found some of the genes associated with lung tumors are also defective in other cancers, that non-smokers with lung cancer have distinct genetic defects and that several molecular pathways underlie most...

2008-09-17 15:00:36

European medical scientists have determined a new form of chemotherapy extends the life of patients with inoperable pancreatic cancer. The scientists led by Karolinska Institute Professor Matthias Lohr determined the chemotherapy, which destroys new blood vessels that grow around tumors, produced excellent results in a phase II trial. The researchers said they evaluated the efficacy and safety of three different doses of cationic lipid complexed paclitaxel, or EndoTAG-1, administered...

2008-09-17 12:00:11

Chinese medical scientists say the drug gefitinib (Iressa) should be considered the first-line therapy for non-smoking Asian patients with lung cancer. Asia has a high proportion of lung cancer patients who are non-smokers, a significant proportion of whom develop a form of cancer known as adenocarcinoma. "Around 50 percent to 60 percent of this population (has tumors) with mutations in the epidermal growth factor receptor and we know that patients with such mutations have a significantly...

2008-09-16 12:00:50

Pfizer has announced updated safety and efficacy results from a Phase II, randomized, non-comparative study surrounding its investigational compound, CP-751,871, in patients with non-small cell lung cancer. Results from a Phase II, randomized, non-comparative study showed that 54% of patients with stage III/IV treatment-naive NSCLC receiving the combination CP-751,871 plus carboplatin and paclitaxel (n=97) experienced objective responses. The response rate was 41% in patients treated with...

2008-08-30 09:00:21

By Anonymous Listed below are questions based on articles that appeared in last month's edition of the ARCHIVES. Registered continuing medical education participants should answer these questions either online or use the August 2008 answer sheet. 1. Which of the following statements concerning Rosai-Dorfman disease is false? a. pulmonary involvement is rare and occurs in approximately 2% to 3% of cases with extranodal disease b. lymphocytes within histiocyte cytoplasm, termed...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related